Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats

Stroke

Volumn 43, Issue 2, 2012, Pages 478-483

  Kinouchi, Tomoya ^a   Kitazato, Keiko T ^a   Shimada, Kenji ^a   Yagi, Kenji ^a   Tada, Yoshiteru ^a   Matsushita, Nobuhisa ^a   Sumiyoshi, Manabu ^a   Satomi, Junichiro ^a   Kageji, Teruyoshi ^a   Nagahiro, Shinji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

cerebral ischemia; ER ; neuroprotection; OVX; p STAT3; PPAR

Indexed keywords

CASPASE 3; ESTROGEN RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FEMALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REPERFUSION;

ANIMALS; APOPTOSIS; BASAL GANGLIA; BRAIN; BRAIN ISCHEMIA; CASPASE 3; CELL NUCLEUS; CEREBRAL INFARCTION; DNA; ESTROGEN RECEPTOR ALPHA; FEMALE; NEUROPROTECTIVE AGENTS; OVARIECTOMY; PPAR GAMMA; PROTEIN TRANSPORT; RATS; RATS, WISTAR; RESPONSE ELEMENTS; STAT3 TRANSCRIPTION FACTOR; THIAZOLIDINEDIONES; TRANSCRIPTIONAL ACTIVATION;

EID: 84856484893     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.618926     Document Type: Article

References (26)

1. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet. 1999; 23:1457-1463. (Pubitemid 29494766)
2. Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci USA. 2007;104:6013-6018. (Pubitemid 47175650)
3. Bjornstrom L, Sjoberg M. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol Endocrinol. 2002;16:2202-2214. (Pubitemid 35155534)
4. De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest. 2010;1: 2395-2405.
5. Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3:651-662. (Pubitemid 34987786)
6. Lai SY, Johnson FM. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches. Drug Resist Updat. 2010;13:67-78.
7. Stephanou A, Brar BK, Knight RA, Latchman DS. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-xL promoters. Cell Death Differ. 2000;7:329-330. (Pubitemid 30192982)
8. Dziennis S, Jia T, Rønnekleiv OK, Hurn PD, Alkayed NJ. Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection. J Neurosci. 2007;27:7268-7274. (Pubitemid 47037568)
9. Tureyen K, Kapadia R, Bowen KK, Satriotomo I, Liang J, Feinstein DL, et al. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem. 2007;101:41-56. (Pubitemid 46426485)
10. Mitka M. Studies explore stroke's gender gap. JAMA. 2006;295: 1755-1756.
11. Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, Laage R, et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005;115: 2083-2098. (Pubitemid 41134150)
12. Li Q, Zhang R, Guo YL, Mei YW. Effect of neuregulin on apoptosis and expressions of STAT3 and GFAP in rats following cerebral ischemic reperfusion. J Mol Neurosci. 2009;37:67-73.
13. Shyu WC, Lin SZ, Chiang MF, Chen DC, Su CY, Wang HJ, et al. Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J Clin Invest. 2008;118: 133-148.
14. Shulman AI, Mangelsdorf DJ. Retinoid X receptor heterodimers in the metabolic syndrome. N Engl J Med. 2005;353:604-615. (Pubitemid 41138942)
15. Nettles KW. Insights into PPAR gamma from structures with endogenous and covalently bound ligands. Nat Struct Mol Biol. 2008;15:893-895.
16. Kliewer SA, Xu HE, Lambert MH, Willson TM. Peroxisome proliferatoractivated receptors: from genes to physiology. Recent Prog Horm Res. 2001;56:239-263.
17. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR alpha. Nature. 2002;415:813-817. (Pubitemid 34150506)
18. Wong LH, Saffery R, Anderson MA, Earle E, Quach JM, Stafford AJ, et al. Analysis of mitotic and expression properties of human neocentromere-based transchromosomes in mice. J Biol Chem. 2005;280: 3954-3962. (Pubitemid 40223865)
19. Victor NA, Wanderi EW, Gamboa J, Zhao X, Aronowski J, Deininger K, et al. Altered PPARgamma expression and activation after transient focal ischemia in rats. Eur J Neurosci. 2006;24:1653-1663. (Pubitemid 44427534)
20. Sundararajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD, Landreth GE. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience. 2005;130:685-696. (Pubitemid 39601441)
21. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med. 2008;14:497-500. (Pubitemid 351655209)
22. Rau SW, Dubal DB, Böttner M, Gerhold LM, Wise PM. Estradiol attenuates programmed cell death after stroke-like injury. J Neurosci. 2003;23:11420-11426. (Pubitemid 37549698)
23. Shimada K, Kitazato KT, Kinouchi T, Yagi K, Tada Y, Satomi J, et al. Activation of estrogen receptor-αand of angiotensin-converting enzyme 2 suppresses ischemic brain damage in oophorectomized rats. Hypertension. 2011;57:1161-1166.
24. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Löwik CW. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem. 2003;278: 962-967. (Pubitemid 36790772)
25. Wang LH, Yang XY, Zhang X, Farrar WL. Nuclear receptors as negative modulators of STAT3 in multiple myeloma. Cell Cycle. 2005;4:242-245. (Pubitemid 41365326)
26. Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM, Walker CL. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. Cancer Res. 2003;63:1221-1227. (Pubitemid 36348698)